共 90 条
[1]
Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicity
[J].
CANCER RADIOTHERAPIE,
2017, 21 (02)
:114-118
[3]
Angelo K, 2014, ANTICANCER RES, V34, P877
[4]
Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG)
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2016, 95 (02)
:632-646
[5]
[Anonymous], DEV RAPID ACCESS RAD
[6]
[Anonymous], MODERN PRACTICES RAD
[8]
Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2017, 98 (02)
:344-351